ArticleCardiovascular and interventional radiology2025
One-year Clinical Outcomes and Predictors of Distal Embolization After JETSTREAM™ Atherectomy for Calcified Femoropopliteal Artery Lesions: Results From the JET-FORWARD Study.
Article in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Drug-coated balloon alone versus atherectomy plus drug-coated balloon for treatment of femoropopliteal atherosclerotic disease: a meta-analysis.Journal of cardiothoracic surgery · 2026Pooled it
- Two-year clinical outcomes of jetstream atherectomy followed by drug-coated balloon angioplasty for severely calcified femoropopliteal lesions.Heart and vessels · 2026Article
- High Embolic Risk with Orbital Atherectomy for Calcified Peripheral Artery Disease.Annals of biomedical engineering · 2026Article
- Debulking Severe Femoropopliteal Calcification: Mechanical Gain, Biological Limits, and Embolic Risk.JACC. Asia · 2026Article
- Clinical Impacts and Procedural Risks of Rotational Atherectomy for Heavily Calcified Femoropopliteal Lesions.JACC. Asia · 2026Article
- Low-Dose Versus High-Dose Drug-Coated Balloon After Jetstream Atherectomy for Severely Calcified Femoropopliteal Lesions: A Multicenter Registry Study.Cardiovascular and interventional radiology · 2026Article
- Rotational atherectomy via retrograde popliteal access without embolic protection for complex femoropopliteal lesions.CVIR endovascular · 2026Article
- Reverse flow-controlled atherectomy treatment using the JETSTREAM atherectomy device for reducing distal embolization.Journal of vascular surgery cases and innovative techniques · 2026Article
- Atherectomy With Multimodal Embolic Protection for Severely Calcified Femoropopliteal Lesions.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026Article
- Association between discharge destination and medium-term mortality in patients with chronic limb-threatening ischemia after endovascular therapy: results of the DENEB study.Heart and vessels · 2026Article
- Incidence and Predictors of In-Hospital Frailty Progression in Patients with Chronic Limb-Threatening Ischemia after Endovascular Therapy: Results of the RIGEL Study.Journal of atherosclerosis and thrombosis · 2026Article
- Three-year outcomes of a prospective, multicenter study of rotational atherectomy with antirestenotic therapy for infrainguinal arterial disease.Annals of surgical treatment and research · 2026Article
- Efficacy and costs of combined balloon dilation plus atherectomy versus combined balloon dilation plus stent for lower-limb peripheral arterial disease: a single-center propensity-matched retrospective cohort study.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to identify predictors of distal embolization following JETSTREAM™ atherectomy for calcified femoropopliteal lesions and evaluate 1-year clinical outcomes in a real-world setting. MATERIALS AND
methodsWe analyzed data from 109 patients with 121 calcified femoropopliteal lesions who underwent JETSTREAM™ atherectomy therapy between October 2022 and December 2023 as part of the JET-FORWARD study, a retrospective, single-arm, multicenter study. Distal embolization incidence and risk factors were the primary focus, while 1-year primary patency served as efficacy outcome measures. Safety outcomes also included mortality and major target limb amputation.
resultsThe mean lesion length was 15.5 ± 9.4 cm, and the technical success rate-defined as residual stenosis less than 30% and absence of grade C or higher dissection post-procedure-was 93.4%. Angiographically significant distal embolization occurred in 35.5% of cases during the index procedure. On multivariate analysis, poor tibial runoff (≤ 1 tibial artery), severe small artery disease, nodular calcification, and debulking lengths > 10 cm were independent predictors of distal embolization. The 1-month mortality and 1-year limb salvage rates were 2.8% and 98.9%, respectively. The 1-year primary patency rate was 88.9%.
conclusionAngiographically significant distal embolization occurred in 35.5% of cases with JETSTREAM atherectomy, while 1-year outcomes remained favorable in treating femoropopliteal lesions. This study also identified four predictors of distal embolization. Thus, careful risk factor evaluation and patient selection are essential during atherectomy.
Indexed as
Identifiers
40404999What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.